Navigation Links
NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility
Date:10/10/2008

PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuView Life Sciences Inc. (NuView) has agreed to assume management of Trace Life Sciences Inc. (Trace), including operations of the linear accelerator and cyclotron production facilities in Denton, Texas. The Trace facility produces Copper-64, Copper- 67, Indium-111, Iodine-123 and Thallium-201 used in molecular imaging and nuclear medicine. Paul Crowe, NuView Chairman and CEO, stated that "We are confident that by improving operational efficiencies at Trace, combined with our national sales force, we will provide customers a viable resource for their clinical needs." Added NuView's Chief Medical Officer Peter Conti, M.D., Ph.D., FACR, FACNP, "Using the unique capabilities of this facility, we anticipate the ability to produce novel radioisotopes to satisfy unmet needs of the research community."

About NuView Life Sciences Inc.

NuView Life Sciences Inc., a Utah-based life-sciences company, is focused on identifying and developing emerging novel diagnostic or targeted therapies. NuView partners with private enterprise and university-based researchers whom it believes have developed promising new products which may offer significant improvement over current diagnostic or therapeutic approaches for cardiology and cancer disorders. NuView also distributes approved pharmaceutical and medical-device products routinely utilized in clinical practice today. For more information about NuView, please call 866-577-7764 or visit http://www.nuviewinfo.com.


'/>"/>
SOURCE NuView Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
2. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
3. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
4. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
5. Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec
6. Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films
7. ev3 Inc. to Present at the 2008 UBS Global Life Sciences Conference
8. Cyberonics to Present at UBS Global Life Sciences Conference
9. [video] Hojabr Alimi, CEO of Oculus Innovative Sciences, Inc. Discusses Reduction of Planned Expenses on WallSt.nets 3-Minute Press Show
10. Particle Sciences Develops Zero-Order-Release Combination Device Technology
11. Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Key Factor in Decision for Florida Multi-Specialty...PRNewswire-FirstCall/ -- Allscripts announced toda...t multi-specialty group practices in the Southeast...rise(TM) Electronic Health Record (EHR) to automat...ross Central Florida. , , (Logo: http://www....
(Date:1/8/2009)...e-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYS...the fourth quarter of 2008 it acquired Maine Artif...rthotic-Prosthetics Center, Riessen,s Orthopedic a...s & Prosthetics, and Orthopedic Rehabilitation...e centers to existing markets in Maine, Louisiana,...
(Date:1/8/2009)...Newswire/ -- The Pew Charitable Trusts announced t...hemical and food safety programs, in its Health &a...formerly deputy staff director and general counsel... Works, brings nearly 25 years of experience in en..., , "We are excited to be joined by such an exp...
(Date:1/8/2009)...ss continues to drive overall performance , , D...ation (ZixCorp(R)), (Nasdaq: ZIXI ), the leader ...cribing, today offered a corporate update by its c...ed the year on a high note in our Email Encryption... year in the fourth quarter," said Spurr. "Our ne...
Breaking Medicine News(10 mins):Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4
...ection between MMR(measles, mumps and rubella) va...concern over the safety of the vaccine, despite ...nd all the Royal Colleges //. An inquiry is to b...lth, and tests are to be carried out on children w...
... spells heaven for millions of avian influenza pat...e Children’s Research Hospital //. According to th...s potent against one antigenic variant of the avia...is that this vaccine also has the ability to prote...
...ple across the globe die every year of environment...HO) study revealed Friday//. The four main disease...rrhoea, lower respiratory tract infection, various...juries and malaria, said a WHO statement. The repo...
...a guess on what could be top of the heap among Bri...ow out in the open as a common affliction// , need... issue that is threatening to become a social prob...million people avail an incapacity benefit due to ...
Other Medicine News:Health News:Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants 2Health News:13 million environment-linked deaths every year: WHO 2
(Date:1/6/2009)...from prior U.S., U.K. and China Trials , , SAN .... (VTI), a development stage company targeting liv... begun for a randomized, controlled, multi-center,...orporeal Liver Assist Device (ELAD) as a treatment... three protocols. The study is open for enrollment...
(Date:1/6/2009)...-- Cequent Pharmaceuticals, a pioneer in the devel...atments to prevent and treat human disease, announ...essful toxicology study of its candidate CEQ501, a...ng the primary oncogene (beta-catenin, CTNNB1) in ...herited gastrointestinal disease that causes hundr...
(Date:1/5/2009)...re/ -- Women undergoing in vitro,fertilization (I...t early,pregnancy, but the intramuscular injectio...ul for patients. Formulations of progesterone med... injection or vaginal suppository may offer,simil... With patient well-being a constant focus, Fertili...
(Date:12/27/2008)...wire/ -- According to the latest,science, resvera... doses of,resveratrol plus an array of antioxidan...es of aged, red wine, rather than resveratrol alon...in/prnh/20080603/LATU039 ) , The most rece...o prolong,the life of laboratory mice. In fact, ...
Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Gene Variant Doubles Risk of Prostate Cancer in Black Men 5399 1Gene Variant Doubles Risk of Prostate Cancer in Black Men 5399 2Palatin Technologies to Present at the Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 5397 115th Anniversary Celebration Shoot For a Cure Event Slated for Nov 8 5395 1Scientists discover novel way to remove iron from ferritin 1088 1
...uly 11, 2007 /PRNewswire-FirstCall/ -- On Wednesda...astern/10:30 p.m.,Central European Time members of...ill host a conference call to discuss today,s,anno...I RAPID trial,comparing CHOP-R to CPOP-R, in which...dard CHOP-R, in first-line treatment of patients,w...
...ion ,Automation continues to gain importance in...ing test consolidation, rising demands from clinic...ing shortage of licensed medical technologists. Ul...lity automation solutions are better equipped to m...t of overall laboratory automation (e.g. sample pr...
Other Medicine Technology:Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5
2.5 mm cups angled 50 degrees, 10 mm from angle to tip. Serrated handle with polished finish.
Two rows of teeth on jaws provide a firm purchase on the nucleus fragment for removal. Flat handle with dull finish.
Puntenney curved forceps, curved, smooth 10 mm platforms.
Curved, very delicate, smooth jaws with platforms., ,Straight, very delicate, smooth jaws with platforms.
Medicine Products: